DCUN1D1 Rekombinanter Antikörper

DCUN1D1 Rekombinant Antikörper für WB, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus

Anwendung

WB, ELISA

Konjugation

Unkonjugiert

CloneNo.

250196B5

Kat-Nr. : 85849-4-RR

Synonyme

DCN1, DCN1 like protein 1, DCN1-like protein 1, DCNL1, DCUN 1D1

---

• 

  WB analysis using 85849-4-RR

  Various lysates were subjected to SDS PAGE followed by western blot with 85849-4-RR (DCUN1D1 antibody) at dilution of 1:10000 incubated at room temperature for 1.5 hours.

• 

  Affinity and Kinetic Characterization of 85849-4-RR

  Biolayer interferometry (BLl) kinetic assays of 85849-4-RR against Human DCUN1D1 were performed. The affinity constant is 23.8 pM.

---

Geprüfte Anwendungen

• Erfolgreiche Detektion in WB: A549-Zellen, HeLa-Zellen, HepG2-Zellen, HT-29-Zellen, Jurkat-Zellen, Maushirngewebe

Empfohlene Verdünnung

• Western Blot (WB): WB : 1:5000-1:50000

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Produktinformation

85849-4-RR bindet in WB, ELISA DCUN1D1 und zeigt Reaktivität mit human, Maus

• Getestete Reaktivität: human, Maus
• Wirt / Isotyp: Kaninchen / IgG
• Klonalität: Rekombinant
• Typ: Antikörper
• Immunogen: DCUN1D1 fusion protein Ag1440
• Vollständiger Name: DCN1, defective in cullin neddylation 1, domain containing 1 (S. cerevisiae)
• Berechnetes Molekulargewicht: 30 kDa
• Beobachtetes Molekulargewicht: 30 kDa
• GenBank-Zugangsnummer: BC009478
• Gene symbol: DCUN1D1
• Gene ID (NCBI): 54165
• Konjugation: Unkonjugiert
• Form: Liquid
• Reinigungsmethode: Protein-A-Reinigung
• Lagerungspuffer: PBS with 0.02% sodium azide and 50% glycerol
• Lagerungsbedingungen: Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20^oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

It has been found that DCUN1D1, also known as squamous cell carcinoma-related oncogene, expression may play a role in development of brain metastasis in patients with Non-small cell lung carcinoma (NSCLC). DCUN1D1-positive tumor cells may have the ability to disrupt the blood-brain-barrier and colonize the brain.